RSNA 2025 marked a shift in radiology from AI experimentation to market realignment. Point solutions are giving way to foundational models, workflow orchestration, and vertically integrated platforms that reduce friction and protect margins. As capital returns with a focus on…

Integrating regulatory requirements early in the medical device development process helps startups avoid costly delays, redesigns, and recalls. By embedding risk management, usability, and compliance from the start, teams can reduce testing cycles, speed up CE marking or FDA clearance,…

Test Labs wrapped up 2025 at GIANT Health Event with standout engagement and meaningful conversations with new and emerging innovators. The energy, ideas, and interest in Outlook 2026 Annual made it a powerful end-of-year highlight.

Patient involvement is vital to MedTech, driving safer device design, effective compliance, and stronger innovation through engagement forums, safety principles, and national registries.

Startups face major challenges navigating FDA and MDR simultaneously due to classification, evidence, and timing mismatches.

Test Labs attended MD&M Midwest 2025 to strengthen connections with US medtech manufacturers and deepen collaboration across the Atlantic. The event delivered valuable conversations around biocompatibility and material compatibility testing, reinforcing the importance of early engagement.

Patient-specific 3D printing is transforming how surgeons plan operations and how MedTech companies design, test, and validate devices. As healthcare moves toward greater personalisation, 3D printing is set to become integral to surgery, training, and medical device innovation.